South Wales, July 25 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "LAZVUE" on July 16. The details about the trademark application no. UK00004234795 published in the journal no. 2025/030 (July 25).
With J A Kemp LLP as representative, BEACON THERAPEUTICS LIMITED filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical preparations and substances; preparations for gene therapy and cell therapy; Pharmaceutical preparations and substances for the treatment of ocular disorders; biotechnological preparations for the treatment of ocular disorders; preparations for gene therapy and cell therapy for the treatment of ocular disorders; genetic medicines for the treatment of ocular disorders.
Class 10 : Medical apparatus and instruments; medical apparatus and instruments used in the treatment of ocular disorders; apparatus and instruments for the administration of pharmaceutical preparations; apparatus and instruments for the injection of pharmaceutical preparations; medical apparatus and instruments for use in gene therapy and cell therapy.
Class 44 : Medical treatment services; Provision of medical information and services; Information provided to patients and healthcare professionals concerning pharmaceutical products, preparations for gene therapy and cell therapy, medical diseases and disorders and related treatments; Medical treatment services in the field of ocular disorders; Provision of medical information and services in the field of ocular disorders.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004234795
Disclaimer: Curated by HT Syndication.
